FindTrial
Sign In

The practice and research of risk stratification management model in neonatal hyperbilirubinemia

The practice and research of risk stratification management model in neonatal hyperbilirubinemia

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800015180
Enrollment
Unknown
Registered
2018-03-12
Start date
2017-07-01
Completion date
Unknown
Last updated
2018-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neonatal hyperbilirubinemia

Interventions

term and late preterm infants:risk stratification management model

Sponsors

Shanghai Children's Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: term and late preterm infants (gestational age is greater than 35 weeks, birth weight is greater than 2000g)

Exclusion criteria

Exclusion criteria: (1) because of other reasons transfer to neonatal wards after birth(namely all kinds of neonatal illness requiring hospitalization, such as neonatal meconium aspiration syndrome, neonatal pneumonia, early septicemia, etc.);(2)infants who have ABO/Rh hemolytic disease of newborn; (3) children who had received phototherapy within 72h after birth; (4) the G6PD deficiency; (5) infants who have congenital malformations or metabolic diseases.

Design outcomes

Primary

MeasureTime frame
transcutaneous bilirubin;—

Countries

China

Contacts

Public ContactSun Jianhua

Shanghai Children's Medical Center

jianhs@126.com+86 18930830602

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026